Trevogrumab

N/A

Report date: 2025/02/24 16:50:54

Base Information

Drug NameTrevogrumab
Drug Alias NameREGN-1033REGN1033SAR-391786GDF8
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionGrowth/differentiation factor 8 inhibitors
TargetsGrowth/differentiation factor 8
Therapy Area/IndicationsObesitySarcopeniaMyositis, Inclusion Body
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoNetherlands +[6
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRegeneron Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsSarcopeniaMyositis, Inclusion Body

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG